Corrigendum: Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects

Corrigendum: Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects

Bibliographic Details
Main Authors:	Ying Zhou, Pei Hu, Yuguang Huang, Nuoer Sang, Kaicheng Song, Hongyun Wang, Jinhua Wen, Ji Jiang, Xia Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-03-01
Series:	Frontiers in Pharmacology
Subjects:	population pharmacodynamics population pharmacokinetics sedation modeling benzodiazepine
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2019.00251/full

Similar Items

The relationship between the effect-site concentration of propofol and sedation scale in children: a pharmacodynamic modeling study
by: Young-Eun Jang, et al.
Published: (2021-09-01)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
by: Roganović Maša, et al.
Published: (2021-01-01)

Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic
by: Juan Liao, et al.
Published: (2022-02-01)

Remimazolam: pharmacological characteristics and clinical applications in anesthesiology
by: Kyung Mi Kim
Published: (2022-01-01)

Pharmacodynamics and pharmacokinetics of nalbuphine in xylazine‑sedated horses
by: Amal Hammad, et al.
Published: (2023-05-01)

Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
by: Xiao-Qin Liu, et al.
Published: (2023-02-01)

Alfaxalone population pharmacokinetics in the rat: Model application for pharmacokinetic and pharmacodynamic design in inbred and outbred strains and sexes
by: Kate White, et al.
Published: (2022-12-01)

Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis
by: Yue-E Wu, et al.
Published: (2022-12-01)

Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia
by: Sutep Jaruratanasirikul, et al.
Published: (2015-02-01)

Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population
by: Bing Chen, et al.
Published: (2022-07-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

Simulation-Based Gastrointestinal Endoscopy Sedations: A Novel Validation to Multidrug Pharmacodynamic Modeling
by: Jing-Yang Liou, et al.
Published: (2022-09-01)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
by: Yuancheng Chen, et al.
Published: (2023-02-01)

Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol
by: Ebrahim Salehifar, et al.
Published: (2017-06-01)

Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers
by: Aitana Calvo, et al.
Published: (2022-02-01)

Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis
by: Qian Li, et al.
Published: (2022-08-01)

Pharmacodynamic modeling of moderate sedation and rationale for dosing using midazolam, propofol and alfentanil
by: Jing-Yang Liou, et al.
Published: (2023-01-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Opioid and/or Psychotropic Use Increases Intraprocedural Sedation Drug Requirements
by: Sreeja Sanampudi, et al.
Published: (2022-04-01)

Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
by: Dong-Seok Lee, et al.
Published: (2018-04-01)

Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01)

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
by: Noriyuki Ishihara, et al.
Published: (2020-03-01)

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia
by: Rong-Rong Li, et al.
Published: (2019-05-01)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
by: Alexandre Le Marouille, et al.
Published: (2021-10-01)

Sedation in critically ill children with respiratory failure
by: Nienke J Vet, et al.
Published: (2016-08-01)

Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic–Pharmacodynamic Modeling
by: Seung-Hyun Jeong, et al.
Published: (2023-11-01)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
by: Maria Kipourou, et al.
Published: (2023-02-01)

Sedation level with midazolam: A pediatric surgery approach
by: Carmen Flores-Pérez, et al.
Published: (2022-07-01)

ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO
by: Shekar Kiran, et al.
Published: (2012-11-01)

Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints
by: Heleen J. Blussé van Oud-Alblas, et al.
Published: (2019-01-01)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
by: Jianbin Min, et al.
Published: (2018-09-01)

Pharmacokinetic and pharmacodynamic correlation of plasma concentrations and blood pressure in hypertensive patients: A study
by: Mahvash Iram, et al.
Published: (2016-01-01)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
by: Hao Liang, et al.
Published: (2024-03-01)

Understanding inter-individual variability in pharmacokinetics/pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes
by: Yingying Xin, et al.
Published: (2022-12-01)

Pharmacodynamics and pharmacokinetics interaction between nefopam and tramadol in the broiler chicks model
by: Yaareb J. Mousa, et al.
Published: (2022-04-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers
by: Gillen M, et al.
Published: (2016-11-01)

Pharmacokinetics of Chinese medicines: strategies and perspectives
by: Ru Yan, et al.
Published: (2018-05-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)